ASRGL1: A potential therapeutic target in the treatment of hepatocellular carcinoma?
Dig Liver Dis
.
2023 Sep;55(9):1306.
doi: 10.1016/j.dld.2023.03.014.
Epub 2023 Apr 14.
Authors
Jing Zhang
1
,
Yan-Li Hou
2
,
Xiao-Cong Liu
3
,
Hao Dong
4
Affiliations
1
Department of Oncology, Zibo Central Hospital, Zibo 255000, China.
2
Department of Supervision Office of Nursing, Zibo Central Hospital, Zibo 255000, China.
3
Department of Clinical Laboratory, Zibo Central Hospital, Zibo 255000, China.
4
Department of orthopedics, Zibo Central Hospital, Zibo 255000, China. Electronic address: 18560290778@163.com.
PMID:
37062626
DOI:
10.1016/j.dld.2023.03.014
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers, Tumor
Carcinoma, Hepatocellular* / drug therapy
Carcinoma, Hepatocellular* / pathology
Cell Line, Tumor
Humans
Liver Neoplasms* / drug therapy
Liver Neoplasms* / pathology
Substances
Biomarkers, Tumor